Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how Dost-translational modification of proteins Gay be involved in autoimmune disease

References

• Courtenay J S, Dallman M J, Dayan A D, Martin A, Mosedal B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666–8
   PubMed Web of Science ®Google Scholar
• Wooley P H, Luthra H S, Stuart J M, David C S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp Med 1981; 154: 688–700
   PubMed Web of Science ®Google Scholar
• Trentham D E, Townes A S, Kang A H. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp Med 1977; 146: 857–68
   PubMed Web of Science ®Google Scholar
• Cathcart E S, Hayes K C, Gonnerman W A, Lazzari A A, Franzblau C. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest 1986; 54: 26–31
   PubMed Web of Science ®Google Scholar
• Arai K, Yamamura S, Hanyu T, Takahashi H E, Umezu H, Watanabe H, et al. Extrathymic differentiation of resident T cells in the joints of mice with collagen-induced arthritis. J. Immunol 1996; 157: 5170–7
   PubMed Web of Science ®Google Scholar
• Moder K G, Luthra H S, Kubo R, Griffiths M, David C S. Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity 1992; 11: 219–24
   PubMed Web of Science ®Google Scholar
• Maeda T, Saikawa I, Hotokebuchi T, Sugioka Y, Eto M, Murakami Y, et al. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody. Arthritis Rheum 1994; 37: 406–13
   PubMedGoogle Scholar
• Corthay A, Johansson A, Vestberg M, Holmdahl R. Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. Int Immunol 1999; 11: 1065–73
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Jonsson R, Larsson P, Klareskog L. Early appearence of activated CD4 positive T lymphocytes and class II antigen-expressing cells in joints of DBN1 mice immunized with type II collagen. Lab Invest 1988; 58: 53–60
   PubMed Web of Science ®Google Scholar
• Ranges G E, Sriram S, Cooper S M. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp Med 1985; 162: 1105–10
   PubMed Web of Science ®Google Scholar
• Kadowaki K M, Matsuno H, Tsuji H, Tunru I. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol 1994; 97: 212–8
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II–induced arthritis in mice. Characterization of arthritogenic collagen II–specific T cell lines and clones. Scand J Immunol 1985; 22: 295–306
   PubMed Web of Science ®Google Scholar
• Tada Y, Ho A, Koh D R, Mak T W. Collagen-induced arthritis in CD4- or CD8-deficient mice. CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J. Immunol 1996; 156: 4520–6
   PubMed Web of Science ®Google Scholar
• Ehinger M, Vestberg M, Johansson A, Johannesson M, Svensson A, Holmdahl R. Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology 2001; 103: 291–300
   PubMed Web of Science ®Google Scholar
• Corthay A, Hansson A S, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum 2000; 43: 844–51
   PubMedGoogle Scholar
• Holmdahl R, Andersson M, Tarkowski A. Origin of the autoreactive anti-type II collagen response. I: Frequency of specific and multispecific B cells in primed murine lymph nodes. Immunology 1987; 61: 369–74
   PubMed Web of Science ®Google Scholar
• Stuart J M, Cremer M A, Townes A S, Kang A H. Type II collagen induced arthritis in rats. Passive transfer with serum and evidence that IgC anticollagen antibodies can cause arthritis. J. Exp Med 1982; 155: 1–16
   PubMed Web of Science ®Google Scholar
• Stuart J M, Dixon F J. Serum transfer of collagen induced arthritis in mice. J. Exp Med 1983; 158: 378–92
   PubMed Web of Science ®Google Scholar
• Terato K, Hasty K A, Reife R A, Cremer M A, Kang A H, Stuart J M. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol 1992; 148: 2103–8
   PubMed Web of Science ®Google Scholar
• Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111: 521–6
   PubMedGoogle Scholar
• Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol 1988; 140: 1477–84
   PubMed Web of Science ®Google Scholar
• Wooley P H, Luthra H S, Griffiths M M, Stuart J M, Huse A, David C S. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J. Immunol 1985; 135: 2443–51
   PubMed Web of Science ®Google Scholar
• Chiocchia G, Boissier M C, Ronziere M C, Herbage D, Fournier C. T cell regulation of collagen-induced arthritis in mice. 1. Isolation of Type II collagen-reactive T cell hybridomas with specific cytotoxic function. J Immunol 1990; 145: 519–25
   Google Scholar
• Peterman G M, Spencer C, Sperling A I, Bluestone J A. Role of gamma delta T-cells in murine collagen induced arthritis. J Imrnunol 1993; 151: 6546–58
   PubMed Web of Science ®Google Scholar
• Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20: 509–15
   PubMed Web of Science ®Google Scholar
• Plows D, Kontogeorgos G, Kollias G. Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J. Immunol 1999; 162: 1018–23
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L. Homologous Type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum 1986; 29: 106–13
   PubMed Web of Science ®Google Scholar
• Boissier M C, Feng X Z, Carlioz A, Roudier R, Fournier C. Experimental autoimmune arthritis in mice. 1. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis 1987; 46: 691–700
   PubMed Web of Science ®Google Scholar
• Stuart J M, Townes A S, Kang A H. Nature and specificity of the immune response to collagen in type II collagen induced arthritis in mice. J Clin Invest 1982; 69: 673–83
   PubMed Web of Science ®Google Scholar
• Andersson M, Holmdahl R. Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990; 20: 1061–6
   PubMed Web of Science ®Google Scholar
• Malmstrom V, Kjellen P, Holmdahl R. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response. J. Autoimmun 1998; 11: 213–21
   Google Scholar
• Terato K, Hasty K A, Cremer M A, Stuart J M, Townes A S, Kang A H. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp Med 1985; 162: 637–46
   PubMed Web of Science ®Google Scholar
• Brand D D, Myers L K, Terato K, Whittington K B, Stuart J M, Kang A H, et al. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J. Immunol 1994; 152: 3088–97
   PubMed Web of Science ®Google Scholar
• Andersson M, Cremer M, Terato K, Burkhardt H, Holmdahl R. Analysis of Type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen in the DBN 1 mouse. Scand J Immunol 1991; 33: 505–10
   PubMed Web of Science ®Google Scholar
• Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992; 22: 1819–25
   PubMed Web of Science ®Google Scholar
• Krco C J, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra H S, et al. Characterization of the antigenic structure of human type II collagen. J Immunol 1996; 156: 2761–8
   PubMedGoogle Scholar
• Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994; 180: 745–9
   PubMed Web of Science ®Google Scholar
• Corthay A, Backlund J, Broddefalk J, Michaelsson E, Goldschmidt T J, Kihlberg J, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998; 28: 2580–90
   PubMed Web of Science ®Google Scholar
• Doncarli A, Chiocchia G, Stasiuk L M, Herbage D, Boutillon M M, Fournier C, et al. A recurrent valpha17/vbeta10 TCR-expressing T cell clone is involved in the pathogenicity of collagen-induced arthritis in DBN1 mice. Eur J Immunol 1999; 29: 3636–42
   Google Scholar
• Mori L, Loetscher H, Kakimoto K, Bluethmann H, Steinmetz M. Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis. J. Exp Med 1992; 176: 381–8
   PubMedGoogle Scholar
• Osman G E, Cheunsuk S, Allen S E, Chi E, Liggitt H D, Hood L E, et al. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice. Int Immunol 1998; 10: 1613–22
   Google Scholar
• Bayrak S, Holmdahl R, Travers P, Lauster R, Hesse M, Dolling R, et al. T cell response of I-Aq mice to self type II collagen: meshing of the binding motif of the I-Aq molecule with repetitive sequences results in autoreactivity to multiple epitopes. Int Immunol 1997; 9: 1687–99
   PubMedGoogle Scholar
• Rosloniec E F, Brand D D, Whittington K B, Stuart J M, Ciubotaru M, Ward E S. Vaccination with a recombinant V alpha domain of a TCR prevents the development of collagen-induced arthritis. J Immunol 1995; 155: 4504–11
   Google Scholar
• Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994; 24: 1698–702
   PubMed Web of Science ®Google Scholar
• Horn J T, Stuart J M, Chiller J M. Murine T cells reactive to type II collagen. I. Isolation of lines and clones and characterization of their antigen-induced proliferative responses. J Immunol 1986; 136: 769–75
   PubMed Web of Science ®Google Scholar
• Rosloniec E F, Whittington K B, Brand D D, Myers L K, Stuart J M. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Cell Immunol 1996; 172: 21–8
   PubMed Web of Science ®Google Scholar
• Kjellen P, Brunsberg U, Broddefalk J, Hansen B, Vestberg M, Ivarsson I, et al. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256–270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol 1998; 28: 755–67
   PubMed Web of Science ®Google Scholar
• Lambert L E, Berling J S. Structural requirements for recognition of a type II collagen peptide by murine T cell hybridomas. Cell Immunol 1994; 153: 171–83
   Google Scholar
• Michaelsson E, Broddefalk J, Kihlberg J, Engstrom A, Holmdahl R. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur J Immunol 1996; 26: 1906–10
   PubMed Web of Science ®Google Scholar
• Oman G E, Toda M, Kanagawa O, Hood L E. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp Med 1993; 177: 387–95
   Google Scholar
• Chiocchia G, Manoury Schwartz B, Boissier M C, Gahery H, Marche P N, Fournier C. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy. Eur J Immunol 1994; 24: 2775–83
   Google Scholar
• Ortman R A, Holderbaum D, Qu X M, Banerjee S, Haqqi T M. BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type II collagen-induced arthritis. J. Immunol 1994; 152: 4175–82
   Google Scholar
• Nabozny G H, Bull M J, Hanson J, Griffiths M M, Luthra H S, David C S. Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med 1994; 180: 517–24
   PubMedGoogle Scholar
• Jirholt J, Cook A, Emahazion T, Sundvall M, Jansson L, Nordquist N, et al. Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol 1998; 28: 3321–8
   Google Scholar
• Chiocchia G, Boissier M C, Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur J Immunol 1991; 21: 2899–905
   PubMed Web of Science ®Google Scholar
• Nagler-Anderson C, Bober L A, Robinson M E, Siskind G W, Thorbecke G J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986; 83: 7443–6
   PubMed Web of Science ®Google Scholar
• Garcia G, Komagata Y, Slavin A J, Maron R, Weiner H L. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J Autoimmun 1999; 13: 315–24
   PubMedGoogle Scholar
• Myers L K, Seyer J M, Stuart J M, Kang A H. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 1997; 90: 161–4
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Ametani A, Hachimura S, Iwaya A, Taguchi Y, Fujita K, et al. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis. Clin Immunol Immunopathol 1998; 88: 70–9
   PubMedGoogle Scholar
• Wooley P H, Luthra H S, Krco C J, Stuart J M, David C S. Type II collagen-induced arthritis in mice. 11. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum 1984; 27: 1010–7
   PubMed Web of Science ®Google Scholar
• Myers L K, Stuart J M, Seyer J M, Kang A H. Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med 1989; 170: 1999–2010
   PubMed Web of Science ®Google Scholar
• Gumanovskaya M L, Myers L K, Rosloniec E F, Stuart J M, Kang A H. Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology 1999; 97: 466–73
   PubMedGoogle Scholar
• Chu C Q, Londei M. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis. J. Autoimmun 1999; 12: 35–42
   PubMedGoogle Scholar
• Khare S D, Krco C J, Griffiths M M, Luthra H S, David C S. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 1995; 155: 3653–9
   PubMed Web of Science ®Google Scholar
• Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA 1996; 93: 4480–5
   PubMed Web of Science ®Google Scholar
• Malmstrom V, Backlund J, Jansson L, Kihlberg J, Holmdahl R. T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res 2000; 2: 315–26
   Google Scholar
• Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 1993; 262: 4224
   Google Scholar
• Heath W R, Carbone F R, Bertolino P, Kelly J, Cose S, Miller J F. Expression of two T cell receptor alpha chains on the surface of normal murine T cells. Eur J Immunol 1995; 25: 1617–23
   PubMed Web of Science ®Google Scholar
• Corthay A, Nandakumar K S, Holmdahl R. Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in auto-immunity. J Autoimmun 2001; 16: 423–9
   Google Scholar
• Zal T, Weiss S, Mellor A, Stockinger B. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc Natl Acad Sci USA 1996; 93: 9102–7
   Google Scholar
• Sollid L M. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53–81
   PubMed Web of Science ®Google Scholar